AAD
  • Meeting Program
  • Registration
  • Daily Coverage
  • Photo Gallery
Topics
  • Daily Coverage
  • Photo Gallery
Resources
  • Meeting Program
  • Registration
Facebook iconInstagram iconTwitter X icon
Jul 17, 2026

Seeing is believing

Learn how AI can improve optical imaging, assist dermatopathology, support clinical decision-making, and enhance care.


Ia26 Ai Technology

Artificial intelligence (AI) is making inroads across all areas of medicine, and dermatology is no exception. According to Manu Jain, MD, physicians are seeing benefits from the use of AI, and optical imaging is one field where it is being increasingly integrated into practice.

Dr. Jain will be part of a panel discussing this and other dermatologic advances in today’s session, POH07 – AI/Technology in Dermatology.

Optical imaging technologies, such as reflectance confocal microscopy, optical coherence tomography, and line field confocal OCT, can noninvasively assess skin cancers to aid in bedside diagnosis and management, said Dr. Jain. But even these methods have their limits and can be enhanced with AI.

“Their adoption has been limited by the expertise needed to interpret them. AI can help overcome this barrier by automating image analysis, highlighting suspicious features, and supporting clinical decision-making,” said Dr. Jain, who is an optical imaging specialist in the department of dermatology at Memorial Sloan Kettering Medical Center in New York.

Jain Manu SquareManu Jain, MD“In the future, I see AI becoming integrated into every stage of the imaging workflow — from image acquisition and quality control to real-time interpretation and longitudinal monitoring — making advanced optical imaging more accessible and practical in routine clinical care,” she said.

One of the biggest benefits AI can bring to dermatologic imaging, Dr. Jain said, is that it can make advanced optical imaging easier to use.

“AI can improve diagnostic consistency, reduce interpretation time, detect subtle imaging features, and help physicians monitor disease over time,” she said. “This has the potential to expand access to technologies that have traditionally required specialized training.”

That’s not to say that there aren’t challenges ahead for AI, Dr. Jain said. Integrating AI into workflows requires large, diverse imaging datasets and the guarantee that algorithms can perform well across different devices and patient populations. One of the biggest challenges though, she said, will be simply understanding what AI’s place is within the medical workflow. It is important to recognize AI as another tool in the toolbox, rather than a miracle solution, she said.

“AI should support clinical decision-making rather than replace physician expertise.”

Another area where AI could play a big role is teledermatology. Dr. Jain said images acquired with optical devices are already in digital formats and can be easily transferred to an expert reader for interpretation.

“As high-quality images are central to remote reading, AI can help by assessing image quality, prioritizing suspicious lesions, and assisting with interpretation,” she said. “As portable imaging devices become more widely available, AI has the potential to bring advanced optical imaging beyond specialist centers and into primary care or underserved communities.”

Today’s session will also feature presentations from Martin Kassir, MD, FAAD; Natalia Khosla, MD, MSc; and Babar K. Rao, MD, FAAD; who will provide real-world examples of a variety of AI applications in dermatology, including robotics, dictation tools, and digital skin mapping.

Interesting Stories
DermWorld June | Optimizing financial efficiency: Part 2
Presented by AAD
DermWorld June | Optimizing financial efficiency: Part 2
DermWorld May | Tackling Stevens-Johnson sydrome/toxic epidermal necrolysis: Part 1
Presented by AAD
DermWorld May | Tackling Stevens-Johnson sydrome/toxic epidermal necrolysis: Part 1
DermWorld March | Optimizing melasma management
Presented by AAD
DermWorld March | Optimizing melasma management
DermWorld April | Exploring Spitz nevi in the molecular era
Presented by AAD
DermWorld April | Exploring Spitz nevi in the molecular era
DermWorld July | Pharm-to-table
Presented by AAD
DermWorld July | Pharm-to-table
More in 2026 AAD Innovation Academy
Jdr 6057
2026 AAD Innovation Academy
2026 AAD Innovation Academy Photo Gallery
Jul 17, 2026
Lisa Bodell
2026 AAD Innovation Academy
Time to think
Jul 17, 2026
Yevgeniy Semenov, MD, MS, FAAD, and Allan C. Halpern, MD, FAAD
2026 AAD Innovation Academy
Carpe diem
Jul 17, 2026
Derm Tank Ia25
2026 AAD Innovation Academy
High risk, high reward
Jul 17, 2026
Ia26 Telederm
2026 AAD Innovation Academy
Let’s face it
Jul 17, 2026
Ia26 Webimage
2026 AAD Innovation Academy
Bright lights, bold ideas!
Jul 16, 2026
Lisa Bodell Aae Headshot 1500x845
2026 AAD Innovation Academy
Discover innovation today
Jul 16, 2026
Ia26 3 Semenov Tsao Halpern
2026 AAD Innovation Academy
Now and next
Jul 16, 2026
Ia26 2 Flamm Han
2026 AAD Innovation Academy
Practice management from every angle
Jul 16, 2026
Ia26 3 Cronin Mobray Burgess
2026 AAD Innovation Academy
Dermatology, Inc.
Jul 16, 2026
Ia26 Derm Surgery
2026 AAD Innovation Academy
The sweet science of dermatologic surgery
Jul 16, 2026
Garg Headshot Primary
2026 AAD Innovation Academy
Hesitating over hidradenitis suppurativa?
Jul 16, 2026
AAD
Facebook iconInstagram iconTwitter X icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.